Transgene and islet cell delivery systems using nano-sized carriers for the treatment of diabetes mellitus

Gene therapy that targets the pancreas and intestines with delivery systems using nano-sized carriers such as viral and non-viral vectors could improve the control of blood glucose levels, resulting in an improved prognosis for patients with diabetes mellitus. Allogenic pancreatic islet cell transpl...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Kiyonori, Ookawara, Susumu, Ishibashi, Kenichi, Morishita, Yoshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167029/
https://www.ncbi.nlm.nih.gov/pubmed/30410709
http://dx.doi.org/10.1080/20022727.2017.1341758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167029/
https://www.ncbi.nlm.nih.gov/pubmed/30410709
http://dx.doi.org/10.1080/20022727.2017.1341758

Ejemplares similares